When are NSAIDs appropriate in osteoarthritis?

Drugs and Aging

Volumn 12, Issue 2, 1998, Pages 87-95

  Bird, Howard A ^a  

^a CHAPEL ALLERTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIHYPERTENSIVE AGENT; CYCLOOXYGENASE 2 INHIBITOR; DIURETIC AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; HYALURONIC ACID; MELOXICAM; MISOPROSTOL; NONSTEROID ANTIINFLAMMATORY AGENT; PROPIONIC ACID DERIVATIVE; PROTON PUMP INHIBITOR; STEROID;

CHEMICAL STRUCTURE; DRUG CLASSIFICATION; DRUG COST; DRUG FORMULATION; DRUG HALF LIFE; DYSPEPSIA; GASTROINTESTINAL HEMORRHAGE; HUMAN; INFLAMMATION; INTRAARTICULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; OSTEOARTHRITIS; PATIENT EDUCATION; PEPTIC ULCER; PHYSIOTHERAPY; PRIORITY JOURNAL; REVIEW; RHEUMATOLOGY; STOMACH EROSION; TOPICAL DRUG ADMINISTRATION;

ADRENAL CORTEX HORMONES; ANALGESICS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; HUMANS; INFLAMMATION; INJECTIONS, INTRA-ARTICULAR; OSTEOARTHRITIS; PATIENT EDUCATION; PEPTIC ULCER;

EID: 0031944736     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-199812020-00001     Document Type: Review

References (50)

1. Bullough PG. Section 7 chapter 7. Osteoarthritis: pathology. In: Klippel JH, Dieppe PA, editors. Rheumatology. London: Mosby, 1994: 1-8
2. Cooper C. Section 7 chapter 3. Osteoarthritis: epidemiology. In: Klippel JH, Dieppe PA. editors. Rheumatology. London: Mosby, 1994: 1-4
3. Dieppe PA. Section 7 chapter 4. Osteoarthritis: clinical features and diagnostic problems. In: Klippel JH, Dieppe PA, editors. Rheumatology. London: Mosby, 1994: 1-16
4. Felson DT, Naimark A, Anderson J, et al. The prevalence of knee arthritis in the elderly: the Framingham Osteoarthritis Study. Arthritis Rheum 1987; 30: 914-8
5. 99technetium images and their relationship to symptoms in osteoarthritis of the hands. Br J Rheumatol 1993; 32: 977-81
6. Dieppe PA, Cushnaghan J, Young P, et al. Prediction of progression of joint space narrowing in osteoarthritis of the knee by bone scintigraphy. Ann Rheum Dis 1993; 52: 557-63
7. Fasbender HG. Pathology of rheumatoid diseases. New York: Springer Verlag, 1975
8. Loose LD, de Oliveira R, Sipe JD, et al. A possible systemic component of osteoarthritis (OA): elevated concentrations (by ELISA) of C-reactive protein (CRP) in serum of OA patients and modulation by tenidap [abstract]. Arthritis Rheum 1993; 36 Suppl. 9: S166
9. Bird HA, Tribe CR, Bacon PA. Joint hypermobility leading to osteoarthrosis and chondrocalcinosis. Ann Rheum Dis 1978; 37: 203-11
10. Bird HA. Osteoarthrosis. In: Wright V, editor. Bone and joint disease in the elderly. Edinburgh: Churchill Livingstone, 1983; 23-8
11. Weinberger M, Tierney WM, Booher P, et al. Can the provision of information to patients with osteoarthritis improve functional status? A randomized, controlled trial. Arthritis Rheum 1989; 32: 1577-83
12. Lorig KR, Mazonson PD, Holman HR. Evidence suggesting that health education for self-management in patients with chronic arthritis has sustained health benefits while reducing health care costs. Arthritis Rheum 1993; 36: 439-46
13. Kovar PA, Allegrante JP, MacKenzie CR, et al. Supervised fitness walking in patients with osteoarthritis of the knee: a randomised, controlled trial. Ann Intern Med 1992; 116: 529-34
14. Peterson MGE, Kovar-Toledano PA, Otis JC, et al. Effect of a walking program on gait characteristics in patients with osteoarthritis. Arthritis Care Res 1993; 6: 11-6
15. Puett DW, Griffin MR. Published trials of nonmedicinal and noninvasive therapies for hip and knee osteoarthritis. Ann Intern Med 1994; 121: 133-40
16. Cushnaghan J, McCarthy C, Dieppe PA. Taping the patella medially: a new treatment for osteoarthritis of the knee joint? BMJ 1994; 308: 753-5
17. Hip and knee joint replacements. Drug Ther Bull 1992; 30: 57-60
18. Ike RW, Arnold WJ, Rothschild EW, et al. Tidal irrigation versus conservative medical management in patients with osteoarthritis of the knee: a prospective randomised study. J Rheumatol 1992; 19: 772-9
19. Brodrick A, Preece G, Bird HA, et al. Factors that may influence the prescribing habits of rheumatologists. J Clin Hosp Pharm 1983; 8: 333-8
20. Bradley JD, Brandt KD, Katz BP, et al. Comparison of an anti-inflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee. N Engl J Med 1991; 325: 87-91
21. Brandt KD. Should osteoarthritis be treated with nonsteroidal anti-inflammatory drugs? Rheum Dis Clin North Am 1993; 19: 697-712
22. Williams HJ, Ward JR, Egger MJ, et al. Comparison of naproxen and acetaminophen in a two year study of treatment of osteoarthritis of the knee. Arthritis Rheum 1993; 36: 1196-206
23. Bird HA, Wright V, le Gallez P. A controlled study of two psychotropic agents for the relief of pain in osteoarthrosis. BMJ 1987; 295: 1521-2
24. Articular and periarticular corticosteroid injections. Drug Ther Bull 1995; 33: 67-70
25. Bird HA. Section 8 chapter 16. Pharmacologic approaches: intraarticular and intralesional therapy. In: Klippel JH, Dieppe PA, editors. Rheumatology. London: Mosby, 1994: 1-6
26. Forrest M, Brooks PM. Mechanism of action of non-steroidal anti-rheumatic drugs. Baillieres Clin Rheumatol 1988; 2: 275-94
27. British national formulary. 34th ed. London: British Medical Association/Royal Pharmaceutical Society of Great Britain, 1997 Sep
28. Hayllar J, Smith T, MacPherson A, et al. Nonsteroidal anti-inflammatory drug-induced small intestinal inflammation and blood loss. Arthritis Rheum 1994; 37: 1146-50
29. Griffin MR, Piper JM, Daugherty JR, et al. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 1991; 114: 257-63
30. MacDonald TM, Morant SV, Robinson GC, et al. Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: cohort study. BMJ 1997; 315: 1333-7
31. Henrey D, Dobson A, Turner C. Variability in the risk of major gastrointestinal complications from nonaspirin nonsteroidal anti-inflammatory drugs. Gastroenterology 1993; 105: 1078-88
32. Garcia Rodriguez LA, Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994; 343: 769-72
33. Rational use of NSAIDs for musculoskeletal disorders. Drug Ther Bull 1994; 32 (12): 91-5
34. Huskisson EC, Woolf PC, Baume HW, et al. Four anti-inflammatory drugs - responses and variations. BMJ 1974; 1: 1084-9
35. Committee on Safety of Medicines. Relative safely of oral non-aspirin NSAIDs. Curr Probl Pharmacovig 1994; 20: 9-11
36. Langman MJS, Weil J, Wainwright P, et al. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994; 343: 1075-8
37. Tonkin AL, Wing LMH. Interactions of non-steroidal anti-inflammatory drugs. Baillieres Clin Rheumatol 1988; 2: 455-83
38. Bird HA, Wright V. Localisation of response. In: Bird HA, Wright V, editors. Applied drug therapy of the rheumatic diseases. Bristol: Wright PSG, 1982: 219-34
39. Rational use of NSAIDs for musculoskeletal disorders. Drug Ther Bull 1994; 32 (12): 91-5
40. Walen A, Bader JP, Meinhard C, et al. Effect of omeprazole and ranitidine on ulcer health and relapse rates in patients with benign gastric ulcer. N Engl J Med 1989; 320: 69-75
41. Roth S, Agrawal N, Mahowald M, et al. Misoprostol heals gastroduodenal injury in patients with rheumatoid arthritis receiving aspirin. Arch Intern Med 1989; 149: 775-9
42. Ehsanullah RSB, Page MC, Tildesley G, et al. Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine. BMJ 1988; 297: 1017-21
43. Graham DY, White RH, Moreland LW, et al. Duodenal and gastric ulcer prevention with misoprostol in arthritis patients taking NSAIDs. Ann Intern Med 1993; 119: 257-62
44. Bardhan KD, Bjarnason I, Scott DL, et al. The prevention and healing of acute NSAID-associated gastroduodenal mucosal damage by misoprostol. Br J Rheumatol 1993; 32: 990-5
45. Verdickt W, Moran C, Hantzscel H, et al. A double-blind comparison of the gastroduodenal safety and efficacy of didofenac and a fixed dose combination of diclofenac and misoprostol in the treatment of rheumatoid arthritis. Scand J Rheumatol 1992; 21: 85-91
46. Gagnier P. Review of the safety of diclofenac/misoprostol. Drugs 1993; 45 Suppl. 1: 31-5
47. Wojtulewski JA, Schattenkirchner M, Barcelo P, et al. A six month double-blind trial to compare the efficacy and safety of meloxicam 7.5 mg daily and naproxen 740 mg daily in patients with rheumatoid arthritis. Br J Rheumatol 1996; 35 Suppl. 1: 22-8
48. Bird HA, Ring EFJ. Therapeutic value of arthroscopy. Ann Rheum Dis 1997; 37: 78-9
49. Hochberg MC, Altman RD, Brandt KD, et al. Guidelines for the medical management of osteoarthritis: part I. Osteoarthritis of the hip. Arthritis Rheum 1995; 38: 1535-40
50. Hochberg MC, Allman RD, Brandt KD, et al. Guidelines for the medical management of osteoarthritis: part II. Osteoarthritis of the knee. Arthritis Rheum 1995; 38: 1541-6